Crenolanib T2677
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Crenolanib is an orally bioavailable type III tyrosine kinases inhibitor of PDGFR_/_ and FLT3 (IC50s: 11, 3.2, and 4 nM).
CAS nr:
670220-88-9
Purity:
98%
Molecular Weight:
443,54
SMILES:
CC1(COc2ccc3n(cnc3c2)-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
Formula:
C26H29N5O2
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Angiogenesis,Autophagy,Tyrosine Kinase/Adaptors
Target:
PDGFR,PDGFR,FLT,Autophagy,FLT
